Open Beta
TREN
MetriLume
TREN

US marketsBEAM

SEC-sourced researchBeta

BEAM

Beam Therapeutics Inc.

Company comparison ↗

Data passport

CIK
0001745999
Exchange
Nasdaq
Business activity
Biological Products, (No Diagnostic Substances) · SIC 2836
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 377,709,000.0000 USD; December 2024: 63,518,000.0000 USD; December 2025: 139,743,000.0000 USD377.7M USD0 USD0December 2023December 2024December 2025
BEAM · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023377,709,000.0000Feb 24, 2026
December 202463,518,000.0000Feb 24, 2026
December 2025139,743,000.0000Feb 24, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025139,743,000.0000-79,992,000.0000-345,102,000.00001,481,177,000.0000242,819,000.0000Feb 24, 2026
December 202463,518,000.0000-376,742,000.0000-347,246,000.00001,103,824,000.0000370,279,000.0000Feb 24, 2026
December 2023377,709,000.0000-132,527,000.0000-149,195,000.0000——Feb 24, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

57/100
Profitability0
Growth100
Balance sheet84
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$139.74MJan 1, 2025 – Dec 31, 2025Feb 24, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$63.52MJan 1, 2024 – Dec 31, 2024Feb 24, 202610-K
Net incomeNetIncomeLoss-$79.99MJan 1, 2025 – Dec 31, 2025Feb 24, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$345.1MJan 1, 2025 – Dec 31, 2025Feb 24, 202610-K
Total assetsAssets$1.48BDec 31, 2025Feb 24, 202610-K
Total liabilitiesLiabilities$242.82MDec 31, 2025Feb 24, 202610-K

New filings

Explore methodology ↗